Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ)
CNY 8.34
(0.24%)
CNY 8.34
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 163.74 Million | 195.99 Million | 131.33 Million | 80.06 Million | -28.27 Million | 74.93 Million |
| Net Income | 105.98 Million | 100.66 Million | 81.11 Million | 70.05 Million | 48.3 Million | 24.53 Million |
| Depreciation & Amortization | 69.39 Million | 66.88 Million | 51.58 Million | 52.32 Million | 42.76 Million | 23.86 Million |
| Deferred income taxes | 6.24 Million | 5.46 Million | 7.21 Million | 8 Million | 3.35 Million | 1.79 Million |
| Stock-based compensation | 10.92 Million | 17.33 Million | - | - | - | - |
| Change in working capital | -39.56 Million | -4.27 Million | -11.51 Million | -52.7 Million | -124.58 Million | 25.63 Million |
| Other non-cash items | 3.81 Million | 9.91 Million | 10.15 Million | 10.39 Million | 5.23 Million | 908.92 Thousand |
| Investing Cash Flow | -706.2 Million | -341.98 Million | -444.21 Million | -229.32 Million | -146.46 Million | -51.7 Million |
| Investments in PPE | -214.65 Million | -311.49 Million | -424.67 Million | -229.99 Million | -184.49 Million | -242.37 Million |
| Acquisitions | 232.49 Thousand | 1.11 Million | 437.97 Thousand | 230.59 Million | 562.66 Thousand | 246.02 Million |
| Investment purchases | -653.96 Million | -80 Million | -20 Million | -25 Million | -562.66 Thousand | -332.51 Million |
| Sales/Maturities of investments | 160.56 Million | 50 Million | 20.15 Thousand | 25.06 Million | 37.46 Million | 519.52 Million |
| Other Investing Activities | 1.61 Million | -1.61 Million | 1.10 | -229.99 Million | 562.66 Thousand | -242.37 Million |
| Financing Cash Flow | 955.25 Million | 68.57 Million | 187.67 Million | 397.74 Million | 176.27 Million | -13.48 Million |
| Debt repayment | -155.04 Million | -284.57 Million | -210.68 Million | -303.08 Million | -30.66 Million | - |
| Dividends payments | -15.76 Million | -32.11 Million | -10.93 Million | -10.92 Million | -3.33 Million | -8.94 Million |
| Common Stock Repurchased | -425.47 Thousand | - | - | -9.69 Million | -7.56 Million | - |
| Common Stock Issuance | - | - | - | 9.69 Million | 7.56 Million | - |
| Other Financing Activities | 827.13 Million | 385.25 Million | 420.16 Million | 723.61 Million | 214.47 Million | -4.53 Million |
| Accounts receivables | 22.4 Million | -11.51 Million | -61.27 Million | 55.85 Million | -44.36 Million | -5.35 Million |
| Accounts payables | -23.01 Million | 133.01 Million | 85.34 Million | -19.24 Million | 444.01 Thousand | 49.03 Million |
| Inventory | -45.2 Million | -131.23 Million | -42.79 Million | -97.32 Million | -84.02 Million | -19.83 Million |
| Other working capital | 4.33 Million | 5.46 Million | 7.21 Million | 8 Million | 3.35 Million | 45.47 Million |
| Cash at beginning of period | 78.17 Million | 154.47 Million | 280.4 Million | 36.03 Million | 34.25 Million | 23.93 Million |
| Cash at end of period | 492.8 Million | 78.17 Million | 154.47 Million | 280.4 Million | 36.03 Million | 34.25 Million |
| Capital Expenditure | -214.65 Million | -311.49 Million | -424.67 Million | -229.99 Million | -184.49 Million | -242.37 Million |
| Effect of forex changes on cash | 1.82 Million | 1.12 Million | -737.62 Thousand | -4.11 Million | 243.74 Thousand | 575.97 Thousand |
| Net cash flow / Change in cash | 414.62 Million | -76.29 Million | -125.93 Million | 244.36 Million | 1.77 Million | 10.31 Million |
| Free Cash Flow | -50.9 Million | -115.49 Million | -293.33 Million | -149.92 Million | -212.76 Million | -167.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 26.18 Million | 25.98 Million | 43.56 Million | 105.98 Million | 27.33 Million | 21.62 Million |
| Depreciation & Amortization | - | 23.01 Million | 23.01 Million | 69.39 Million | 69.39 Million | -34.66 Million |
| Deferred income taxes | - | - | - | 6.24 Million | - | 32.92 Million |
| Stock-based compensation | - | - | - | 10.92 Million | 10.92 Million | -16.42 Million |
| Change in working capital | - | - | - | -39.56 Million | -18.46 Million | 16.67 Million |
| Other non-cash items | 51.66 Million | 52.27 Million | -13.81 Million | 3.81 Million | -20.24 Million | -39.47 Million |
| Investing Cash Flow | -252.54 Million | -59.75 Million | -148.67 Million | -706.2 Million | -4.75 Million | -369.42 Million |
| Investments in PPE | -23.25 Million | -25.06 Million | -29.6 Million | -214.65 Million | -43.34 Million | -40.05 Million |
| Acquisitions | 24.14 Thousand | 115.26 Thousand | -3.2 Million | 232.49 Thousand | -90.68 Thousand | 95.48 Thousand |
| Investment purchases | -230 Million | -45.62 Million | -164.42 Million | -653.96 Million | -43.37 Million | -330 Million |
| Sales/Maturities of investments | 682.49 Thousand | 10.82 Million | 48.55 Million | 160.56 Million | 80.56 Million | -95.48 Thousand |
| Other Investing Activities | 24.14 Thousand | 115.26 Thousand | -115.77 Million | 1.61 Million | 1.48 Million | 626.78 Thousand |
| Financing Cash Flow | -114.54 Million | -118.05 Million | 150.19 Million | 955.25 Million | 71.19 Million | 732.17 Million |
| Debt repayment | -105.59 Million | -65.95 Million | -150.11 Million | -155.04 Million | -56.27 Million | -433.76 Million |
| Dividends payments | -8.67 Million | -26.56 Million | -6.92 Million | -15.76 Million | -15.76 Million | -573.89 Thousand |
| Common Stock Repurchased | 12.98 Million | -12.98 Million | - | -425.47 Thousand | -1.33 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -278.31 Thousand | -25.53 Million | 86.57 Thousand | 827.13 Million | 23.36 Million | 1.16 Billion |
| Accounts receivables | - | - | - | 22.4 Million | 22.4 Million | 42.72 Million |
| Accounts payables | - | - | - | -23.01 Million | - | 20.56 Million |
| Inventory | - | - | - | -45.2 Million | -45.2 Million | -26.05 Million |
| Other working capital | - | - | - | 4.33 Million | 4.33 Million | -20.56 Million |
| Cash at beginning of period | 405.58 Million | 525.61 Million | 412.01 Million | 78.17 Million | 367.23 Million | 22.35 Million |
| Cash at end of period | 116.34 Million | 405.58 Million | 534.77 Million | 492.8 Million | 492.8 Million | 367.23 Million |
| Capital Expenditure | -23.25 Million | -25.06 Million | -29.6 Million | -214.65 Million | -43.34 Million | -40.05 Million |
| Effect of forex changes on cash | 685.28 Thousand | 2.52 Million | 1.55 Million | 1.82 Million | 1.11 Million | 1.47 Million |
| Net cash flow / Change in cash | -289.24 Million | -120.03 Million | 122.76 Million | 414.62 Million | 125.57 Million | 344.87 Million |
| Free Cash Flow | 54.59 Million | 30.18 Million | 139.4 Thousand | -50.9 Million | 14.67 Million | -59.4 Million |
4538
CDBDF
UPPR
MSLA
MPZZF
000760